Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05312736 · ClinicalTrials.gov registry record
Gyrate Atrophy Ocular and Systemic Study
A clinical trial of Gyrate Atrophy and Gyrata of Choroid and Retina; Atrophy, sponsored by Jaeb Center for Health Research.
- Active
- Registry status
- 46
- Enrollment target
- 11
- Study locations
NCT05312736 is a study of Gyrate Atrophy and Gyrata of Choroid and Retina; Atrophy that is active but no longer recruiting, run by Jaeb Center for Health Research. The registered enrollment target is 46 participants. The trial reports 11 study locations across 7 states.
The verdict
NCT05312736, a study of Gyrate Atrophy and Gyrata of Choroid and Retina; Atrophy, is active but no longer recruiting, sponsored by Jaeb Center for Health Research.
- ACTIVE NOT RECRUITING
- Registry status
- 46 participants
- Enrollment target
- 11
- Study locations
Study Summary
The Gyrate Atrophy Ocular and Systemic Study characterizes the natural history of ornithine levels and retinal degeneration (RD) associated with disease-causing OAT variants in the presence of standard care dietary treatment regimens over 4 years. The research goal is to understand the impact of OAT mutations on plasma ornithine levels and retinal degeneration. Funding Source- FDA OOPD
Conditions Studied
Study Locations (11)
Other
- Helsinki University Hospital - Helsinki
- Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC1423 - Paris
- University of Tuebingen, Centre for Ophthalmology - Tübingen
- Vista Vision Eye Clinic - Brescia
- Moorfields Eye Hospital - London
California
- University of California San Francisco - San Francisco
Maryland
- Johns Hopkins University, Wilmer Eye Institute - Baltimore
Massachusetts
- Harvard Univ., Massachusetts Eye and Ear Infirmary - Boston
Pennsylvania
- University of Pennsylvania - Philadelphia
Minas Gerais
- INRET Clínica e Centro de Pesquisa - Belo Horizonte
Ontario
- University of Toronto, Hospital for Sick Children - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-11-21 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05312736
The ClinicalTrials.gov registry entry for NCT05312736 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Gyrate Atrophy appearing as the primary indexed condition, and to 0 interventions.
NCT05312736 reports 11 study locations spanning 7 distinct geographic areas - top geographies include Other, California, Maryland.
Frequently Asked Questions
What is clinical trial NCT05312736 about?
NCT05312736 is a clinical study titled "Gyrate Atrophy Ocular and Systemic Study". The Gyrate Atrophy Ocular and Systemic Study characterizes the natural history of ornithine levels and retinal degeneration (RD) associated with disease-causing OAT variants in the presence of standard care dietary treatment regimens over 4 years. The research goal is to understand the impact of OAT...
What is the current status of trial NCT05312736?
This trial is currently active not recruiting. The enrollment target is 46 participants. The study started on 2023-11-21. Estimated completion is 2028-12-31.
What conditions does trial NCT05312736 study?
This clinical trial studies the following conditions: Gyrate Atrophy, Gyrata of Choroid and Retina; Atrophy, Ornithine-δ-aminotransferase, OAT, Chorioretinal Degeneration.
Who is sponsoring clinical trial NCT05312736?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05312736 being conducted?
This trial has 11 study locations across California, Maryland, Massachusetts, Pennsylvania, Minas Gerais. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.